Sorrento Therapeutics Inc., of San Diego, named Martina Molsbergen vice president of business development

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...Burnham Institute for Medical Research, of La Jolla, Calif., appointed Paul Laikind senior vice president of business development and chief business officer...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...Burnham Institute for Medical Research, of La Jolla, Calif., appointed Paul Laikind senior vice president of business development and chief business officer...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

Dendreon Corp., of Seattle, elected Ian Clark and Pedro Granadillo to its board...Five Prime Therapeutics Inc., of San Francisco, appointed Aron Knickerbocker vice president of business development, Marc Belsky vice president of finance and Lauretta Cesario vice president of human resources

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., named Nigel Ray vice president of business development...Ocular Therapeutix Inc., of Waltham, Mass., named Daniel Myers and Bernard Haffey to its board

Vantia Therapeutics, of Southampton, UK, appointed Andrew Crockett vice president of business development

Avid Bioservices Inc., of Tustin, Calif., appoined Truc Le chief operating officer and Christopher Eso vice president of business operations

Sutro Biopharma Inc., of South San Francisco, named Daniel H. Petree to its board, named Henry Heinsohn vice president of development and manufacturing, and Lesley Stolz as vice president of business development

Immucor Inc., of Norcross, Ga., named Geoffrey S. Crouse vice president and chief operating officer...Third Rock Ventures LLC, of Boston, appointed Philip R. Reilly and Gregory L. Verdine venture partners, and Craig M. Greaves recruiting partner

senior vice president of corporate strategy and chief financial officer...NovaBay Pharmaceuticals Inc., of Emeryville, Calif., named Roy J. Wu vice president for business development

SenesTech Inc., of Flagstaff, Ariz., appointed George M. Siegel vice president of business development

Gevo Inc., of Englewood, Colo., hired Chris Ryan as vice president of business development-downstream

Zafgen Inc., of Cambridge, Mass., appointed Matthias Jaffe chief financial officer and vice president of business development

Izumi Bio Inc., of South San Francisco, appointed Berta Strulovici chief technology officer and Dushyant Pathak vice president of business development

It also promoted Jeff Devlin to chief operating officer and Peter Collins to senior vice president of business development

Ascent Therapeutics Inc., of Cambridge, Mass., appointed John Tagliamonte vice president of business development and Michael Houston vice president of preclinical chemistry and CMC...AVI BioPharma Inc., of Portland, Ore., appointed Paul Medeiros senior vice president of business development and chief business officer

Sygnature Chemical Services Ltd., of Nottingham, UK, appointed Paul Clewlow senior vice president of business development, and an executive member of the board

promoted Stephen DiPalma to executive vice president of business operations and chief financial officer

Action Pharma A/S, of Holte, Denmark, appointed Torben Jung Laursen executive vice president of business development...WuXi PharmaTech, of Shanghai, China, added Stewart Hen and Ning Zhao to its board...XTL Biopharmaceuticals Ltd., of Valley Cottage, N.Y., appointed David Grossman and Boaz Shweiger to its board